HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Albert B Reynolds Selected Research

Delta Catenin

1/2021A requirement for p120-catenin in the metastasis of invasive ductal breast cancer.
1/2018Regulation of Epithelial Plasticity Determines Metastatic Organotropism in Pancreatic Cancer.
12/2017p120-Catenin is an obligate haploinsufficient tumor suppressor in intestinal neoplasia.
9/2014DIPA-family coiled-coils bind conserved isoform-specific head domain of p120-catenin family: potential roles in hydrocephalus and heterotopia.
6/2013Is expression of p120ctn in oral squamous cell carcinomas a prognostic factor?
4/2011Deletion of p120-catenin results in a tumor microenvironment with inflammation and cancer that establishes it as a tumor suppressor gene.
1/2011Adenoma formation following limited ablation of p120-catenin in the mouse intestine.
2/2009An essential role for p120-catenin in Src- and Rac1-mediated anchorage-independent cell growth.
1/2006Blocked acinar development, E-cadherin reduction, and intraepithelial neoplasia upon ablation of p120-catenin in the mouse salivary gland.
12/2004Regulation of cadherin stability and turnover by p120ctn: implications in disease and cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Albert B Reynolds Research Topics

Disease

18Neoplasms (Cancer)
01/2019 - 07/2002
6Inflammation (Inflammations)
01/2019 - 06/2010
3Neoplasm Metastasis (Metastasis)
01/2021 - 01/2011
3Carcinoma (Carcinomatosis)
01/2019 - 03/2004
2Breast Neoplasms (Breast Cancer)
01/2021 - 12/2017
2Carcinogenesis
01/2019 - 12/2017
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2018 - 01/2016
1Colitis
01/2019
1Intestinal Neoplasms (Intestinal Cancer)
12/2017
1Pneumonia (Pneumonitis)
05/2015
1Metaplasia
03/2015
1Chronic Pancreatitis
03/2015
1Acquired Immunodeficiency Syndrome (AIDS)
03/2015
1Hydrocephalus (Hydrocephaly)
09/2014
1Virus Diseases (Viral Diseases)
08/2014
1Squamous Cell Carcinoma of Head and Neck
06/2013
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2012
1Adenoma (Adenomas)
01/2011
1Colonic Neoplasms (Colon Cancer)
01/2011
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
06/2010
1Hemorrhage
06/2010

Drug/Important Bio-Agent (IBA)

13Delta CateninIBA
01/2021 - 12/2002
13Cadherins (E-Cadherin)IBA
01/2018 - 12/2002
5CateninsIBA
12/2017 - 12/2002
4Proteins (Proteins, Gene)FDA Link
05/2015 - 03/2011
2Protein Isoforms (Isoforms)IBA
01/2018 - 09/2014
1sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2019
1Dextrans (Dextran)FDA Link
01/2019
1AzoxymethaneIBA
01/2019
1CytokinesIBA
01/2019
1RNA (Ribonucleic Acid)IBA
01/2018
1GlutaminaseIBA
12/2017
1Glutamine (L-Glutamine)FDA Link
12/2017
1LigandsIBA
12/2017
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
12/2017
1rho-Associated KinasesIBA
12/2017
1Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
05/2015
1Surface-Active Agents (Surfactants)IBA
05/2015
1diisopropylamine dichloroacetate (DIPA)IBA
09/2014
1Pathogen-Associated Molecular Pattern MoleculesIBA
08/2014
1Co-Repressor ProteinsIBA
01/2012
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2011
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
04/2011
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
04/2011
1Macrophage Colony-Stimulating FactorIBA
04/2011
1TamoxifenFDA LinkGeneric
01/2011
1AntigensIBA
06/2010
1Phenobarbital (Luminal)FDA Link
06/2010
1EnzymesIBA
10/2008
1Matrix Metalloproteinases (MMPs)IBA
10/2008
1Phosphotransferases (Kinase)IBA
03/2004
1Transcription Factors (Transcription Factor)IBA
07/2002